Where is Biotium located?

Biotium is headquartered in Hayward, United States. It is registered at Fremont, California.

How many employees does Biotium have?

As of Apr 30, 2026, the latest employee count at Biotium is 48.

Is Biotium a funded company?

Biotium is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Biotium rank among its competitors?

Biotium ranks 9th amongst 36 active competitors, of which 8 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was 3Helix, which secured $3.75M in Oct, 2023.

Who are the top competitors of Biotium?

Biotium's top competitors include Nanosphere, NuProbe and Sirigen. Among them, 3Helix secured the most recent funding round in October, 2023.

Biotium - 2026 Company Profile, Team & Competitors

Company Details

Innovative fluorescent solutions and reagents for life science research. They provide a wide array of glowing products for science, including molecular biology reagents, antibodies, conjugates, cellular stains, protein detection tools, and enzyme assays. They cater to diverse research areas like microbiology, neuroscience, and cancer research, offering reagents and kits for fluorescence microscopy, flow cytometry, and in vivo imaging. Their products include DNA/RNA extraction kits, PCR reagents, antibody labeling kits, viability assays, and a range of fluorescent dyes. They also offer technical resources, product selection guides, and customer support to assist researchers in their work. They provide innovative tools for scientific discovery.

Website: biotium.com
Social
Registered Address: Fremont, California

Key Metrics

Founded Year

2001

Location

Hayward, United States

Stage

Unfunded

Ranked

9^th among 36 active competitors

Employee Count

48 as on Apr 30, 2026

Similar Companies

Sirigen & 23 more

View Biotium's full profile

Biotium is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Biotium, Inc. CIN: 943407219 , United States, Active	Dec 31, 1999	-	48 (As on Dec 31, 2024)	-

Biotium has not raised any funding rounds yet.

The founders of Biotium is Fei Mao.

Here are the details of Biotium's key team members:

Fei Mao: Founder of Biotium.
Contact Info: 1 email address

View details of Biotium's Founder profiles and Board Members

Biotium's employee count trend

Biotium has 48 employees as of Apr 26. Here is Biotium's employee count trend over the years:

Uncover Biotium's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Biotium include Nanosphere, NuProbe and Sirigen. Here is the list of Top 10 competitors of Biotium, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Nanosphere 1999, Northbrook (United States), Acquired	Provider of diagnostic tests for personalized medicine	$97.7M	Bain Capital Ventures, Ann Lurie & 8 others	54/100
2nd	NuProbe 2016, George Town (Cayman Islands), Series B	Develops sensitive multiplex tool for QPCR	$61M	Sequoia Capital, BioTrack Capital & 14 others	51/100
3rd	Sirigen 2003, San Diego (United States), Acquired	High sensitivity fluorescence detection technologies for diagnostics and life science applications	$12.1M	Oxford Capital, Seraphim & 7 others	42/100
4th	ATDBio 2005, Southampton (United Kingdom), Acquired	Developer of oligonucleotides	-	Innovate UK, Europa & 1 others	39/100
5th	Montana Molecular 2007, Bozeman (United States), Funding Raised	Fluorescent biosensors and probes	-	NIH SBIR/STTR, HHS	37/100
6th	3Helix 2015, Salt Lake City (United States), Series A	Developer of reagents that specifically bind denatured collagen	$3.75M	BASF, Altitudelab & 2 others	37/100
7th	DestiNA Genomics 2010, Edinburgh (United Kingdom), Seed	Develops non-enzymatic nucleic acid detection technology	$1.9M	Scottish Enterprise, Old College Capital & 2 others	37/100
8th	Goryo Chemical 2012, Sapporo (Japan), Series A	Develops fluorescent probes for life science research	-	Hokkaido Venture Capital, Miyako Capital & 7 others	36/100
9th	Biotium 2001, Hayward (United States), Unfunded	Innovative fluorescent solutions and reagents for life science research	-	-	30/100
10th	Akrotome 2008, Cleveland (United States), Funding Raised	Molecular imaging tech revolutionizing cancer surgery with high-resolution probes	-	BioEnterprise, AIM-HI Accelerator Fund & 1 others	35/100